165 related articles for article (PubMed ID: 28638990)
1. Pharmacological intervention of MKL/SRF signaling by CCG-1423 impedes endothelial cell migration and angiogenesis.
Gau D; Veon W; Capasso TL; Bottcher R; Shroff S; Roman BL; Roy P
Angiogenesis; 2017 Nov; 20(4):663-672. PubMed ID: 28638990
[TBL] [Abstract][Full Text] [Related]
2. The myocardin-related transcription factor MKL co-regulates the cellular levels of two profilin isoforms.
Joy M; Gau D; Castellucci N; Prywes R; Roy P
J Biol Chem; 2017 Jul; 292(28):11777-11791. PubMed ID: 28546428
[TBL] [Abstract][Full Text] [Related]
3. Serum response factor is a critical requirement for VEGF signaling in endothelial cells and VEGF-induced angiogenesis.
Chai J; Jones MK; Tarnawski AS
FASEB J; 2004 Aug; 18(11):1264-6. PubMed ID: 15180964
[TBL] [Abstract][Full Text] [Related]
4. Disruption of profilin1 function suppresses developmental and pathological retinal neovascularization.
Gau D; Vignaud L; Allen A; Guo Z; Sahel J; Boone D; Koes D; Guillonneau X; Roy P
J Biol Chem; 2020 Jul; 295(28):9618-9629. PubMed ID: 32444495
[TBL] [Abstract][Full Text] [Related]
5. CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling.
Evelyn CR; Wade SM; Wang Q; Wu M; Iñiguez-Lluhí JA; Merajver SD; Neubig RR
Mol Cancer Ther; 2007 Aug; 6(8):2249-60. PubMed ID: 17699722
[TBL] [Abstract][Full Text] [Related]
6. Structure-based virtual screening identifies a small-molecule inhibitor of the profilin 1-actin interaction.
Gau D; Lewis T; McDermott L; Wipf P; Koes D; Roy P
J Biol Chem; 2018 Feb; 293(7):2606-2616. PubMed ID: 29282288
[TBL] [Abstract][Full Text] [Related]
7. Actin-binding protein profilin1 promotes aggressiveness of clear-cell renal cell carcinoma cells.
Allen A; Gau D; Francoeur P; Sturm J; Wang Y; Martin R; Maranchie J; Duensing A; Kaczorowski A; Duensing S; Wu L; Lotze MT; Koes D; Storkus WJ; Roy P
J Biol Chem; 2020 Nov; 295(46):15636-15649. PubMed ID: 32883810
[TBL] [Abstract][Full Text] [Related]
8. MICAL2 is expressed in cancer associated neo-angiogenic capillary endothelia and it is required for endothelial cell viability, motility and VEGF response.
Barravecchia I; Mariotti S; Pucci A; Scebba F; De Cesari C; Bicciato S; Tagliafico E; Tenedini E; Vindigni C; Cecchini M; Berti G; Vitiello M; Poliseno L; Mazzanti CM; Angeloni D
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2111-2124. PubMed ID: 31004710
[TBL] [Abstract][Full Text] [Related]
9. Polyphyllin D, a steroidal saponin from Paris polyphylla, inhibits endothelial cell functions in vitro and angiogenesis in zebrafish embryos in vivo.
Chan JY; Koon JC; Liu X; Detmar M; Yu B; Kong SK; Fung KP
J Ethnopharmacol; 2011 Sep; 137(1):64-9. PubMed ID: 21658438
[TBL] [Abstract][Full Text] [Related]
10. Redox modification of nuclear actin by MICAL-2 regulates SRF signaling.
Lundquist MR; Storaska AJ; Liu TC; Larsen SD; Evans T; Neubig RR; Jaffrey SR
Cell; 2014 Jan; 156(3):563-76. PubMed ID: 24440334
[TBL] [Abstract][Full Text] [Related]
11. Isoprostanes inhibit vascular endothelial growth factor-induced endothelial cell migration, tube formation, and cardiac vessel sprouting in vitro, as well as angiogenesis in vivo via activation of the thromboxane A(2) receptor: a potential link between oxidative stress and impaired angiogenesis.
Benndorf RA; Schwedhelm E; Gnann A; Taheri R; Kom G; Didié M; Steenpass A; Ergün S; Böger RH
Circ Res; 2008 Oct; 103(9):1037-46. PubMed ID: 18802021
[TBL] [Abstract][Full Text] [Related]
12. Lipocalin-7 is a matricellular regulator of angiogenesis.
Brown LJ; Alawoki M; Crawford ME; Reida T; Sears A; Torma T; Albig AR
PLoS One; 2010 Nov; 5(11):e13905. PubMed ID: 21085487
[TBL] [Abstract][Full Text] [Related]
13. Stereospecific Inhibitory Effects of CCG-1423 on the Cellular Events Mediated by Myocardin-Related Transcription Factor A.
Watanabe B; Minami S; Ishida H; Yoshioka R; Nakagawa Y; Morita T; Hayashi K
PLoS One; 2015; 10(8):e0136242. PubMed ID: 26295164
[TBL] [Abstract][Full Text] [Related]
14. SRF in angiogenesis: branching the vascular system.
Franco CA; Li Z
Cell Adh Migr; 2009; 3(3):264-7. PubMed ID: 19287204
[TBL] [Abstract][Full Text] [Related]
15. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine inhibits angiogenesis through cytoskeleton remodeling.
Pan L; Yu G; Huang J; Zheng X; Xu Y
Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28864781
[TBL] [Abstract][Full Text] [Related]
17. SKLB1002, a novel potent inhibitor of VEGF receptor 2 signaling, inhibits angiogenesis and tumor growth in vivo.
Zhang S; Cao Z; Tian H; Shen G; Ma Y; Xie H; Liu Y; Zhao C; Deng S; Yang Y; Zheng R; Li W; Zhang N; Liu S; Wang W; Dai L; Shi S; Cheng L; Pan Y; Feng S; Zhao X; Deng H; Yang S; Wei Y
Clin Cancer Res; 2011 Jul; 17(13):4439-50. PubMed ID: 21622720
[TBL] [Abstract][Full Text] [Related]
18. Stimulus-dependent phosphorylation of profilin-1 in angiogenesis.
Fan Y; Arif A; Gong Y; Jia J; Eswarappa SM; Willard B; Horowitz A; Graham LM; Penn MS; Fox PL
Nat Cell Biol; 2012 Oct; 14(10):1046-56. PubMed ID: 23000962
[TBL] [Abstract][Full Text] [Related]
19. Serum response factor is required for sprouting angiogenesis and vascular integrity.
Franco CA; Mericskay M; Parlakian A; Gary-Bobo G; Gao-Li J; Paulin D; Gustafsson E; Li Z
Dev Cell; 2008 Sep; 15(3):448-461. PubMed ID: 18804439
[TBL] [Abstract][Full Text] [Related]
20. Thromboxane A2 receptor signaling inhibits vascular endothelial growth factor-induced endothelial cell differentiation and migration.
Ashton AW; Ware JA
Circ Res; 2004 Aug; 95(4):372-9. PubMed ID: 15242977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
